证券记录 · 已归档季度
ELV
Elevance Health Inc. · Healthcare
19被追踪持有人
+2Δ持有人
43.15M持有股份
$15.91B报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +11.8% ·
股份流向 +14.2% ·
净新建仓位 +10.5%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 688.09K | $266.91M | n/a | −2 |
| Q2 2026 | 176 | +1 | 154.58M | $59.72B | +7 | −8 |
| Q1 2026 | 180 | +5 | 158.67M | $46.48B | +9 | −5 |
| Q4 2025 | 174 | -3 | 171.19M | $60.01B | +1 | −3 |
| Q3 2025 | 26 | +3 | 90.20M | $29.15B | +4 | −2 |
| Q2 2025 | 21 | -2 | 85.20M | $33.13B | +1 | −3 |
| Q1 2025 | 20 | +1 | 41.04M | $17.85B | +2 | −1 |
| Q4 2024 | 19 | +2 | 43.15M | $15.91B | +2 | n/a |
| Q3 2024 | 16 | -2 | 27.12M | $14.09B | +1 | −3 |
| Q2 2024 | 18 | n/a | 29.21M | $15.82B | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 10.68M | n/a | $3.94B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.62M | +4.6% | $3.92B | 0.5% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 6.36M | +42.5% | $2.34B | 0.4% | ▲ Add | 3 | SEC ↗ ×9 |
| 4 | Geode Capital Management ✦ (被动) | 4.96M | +2.4% | $1.83B | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (被动) | 3.08M | +3.4% | $1.14B | 0.1% | ▲ Add | 3 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 2.49M | -10.2% | $917.60M | 0.7% | ▼ Trim | 3 | SEC ↗ ×4 |
| 7 | Harris Associates (Oakmark) ✦ | 1.82M | 新增 | $671.87M | 1.1% | New | 1 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 705.67K | +1181.5% | $260.32M | 0.3% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Arrowstreet Capital ✦ | 699.88K | -11.5% | $258.19M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 501.49K | +247.7% | $185.00M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 418.64K | +19.5% | $154.43M | 0.2% | ▲ Add | 3 | SEC ↗ ×4 |
| 12 | Millennium Management ✦ | 250.06K | +0.8% | $92.25M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 153.90K | +148.0% | $56.77M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 139.93K | +68.2% | $51.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 122.97K | 新增 | $45.36M | 0.1% | New | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 96.63K | -34.3% | $35.65M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 53.69K | +101.4% | $19.80M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 18 | Dodge & Cox ✦ | 1.10K | 0.0% | $405,790 | 0.0% | Held | 3 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 721 | -14.0% | $266,245 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Harris Associates (Oakmark) | $671.87M | 1.1% |
| Renaissance Technologies | $45.36M | 0.1% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,453 持有人, 194.60M 股份, $53.66B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 22
Kaye Mark
Officer · 273 股 · $122,083
Oct 22
Kaye Mark
Officer · 2.34K 股 · $1.03M
Oct 22
Kaye Mark
Officer · 480 股 · $212,453
Oct 22
Kaye Mark
Officer · 440 股 · $195,276
Oct 22
Kaye Mark
Officer · 160 股 · $71,176
Oct 22
Kaye Mark
Officer · 827 股 · $368,883
Oct 22
Kaye Mark
Officer · 400 股 · $173,600
Oct 22
Kaye Mark
Officer · 321 股 · $139,715
Oct 22
Kaye Mark
Officer · 1.66K 股 · $724,092
Oct 22
Kaye Mark
Officer · 560 股 · $244,759
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据